Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status.

Autor: Chin YT; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan., He ZR; Department of Pediatrics, E-Da Hospital, Kaohsiung, Taiwan.; School of Medicine, I-Shou University, Kaohsiung, Taiwan., Chen CL; School of Medicine, Taipei Medical University, Taipei, Taiwan., Chu HC; Division of Medical Imaging, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan., Ho Y; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; School of Pharmacy, Taipei Medical University, Taipei, Taiwan., Su PY; Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Yang YSH; Joint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan., Wang K; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Shih YJ; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Chen YR; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan., Pedersen JZ; Department of Biology, University of Rome Tor Vergata, Rome, Italy., Incerpi S; Department of Sciences, Roma Tre University, Rome, Italy., Nana AW; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan., Tang HY; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States., Lin HY; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States.; TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.; Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan., Mousa SA; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States., Davis PJ; Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States.; Department of Medicine, Albany Medical College, Albany, NY, United States., Whang-Peng J; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; Cancer Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.; Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Jazyk: angličtina
Zdroj: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Apr 09; Vol. 10, pp. 241. Date of Electronic Publication: 2019 Apr 09 (Print Publication: 2019).
DOI: 10.3389/fendo.2019.00241
Abstrakt: [This corrects the article DOI: 10.3389/fendo.2019.00130.].
Databáze: MEDLINE